Biofrontera, Inc. (BFRI)
0.886
+0.03
(+3.02%)
USD |
NASDAQ |
May 29, 16:00
0.8703
-0.02
(-1.77%)
After-Hours: 20:00
Biofrontera Profit Margin (Quarterly) : -47.12% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Rapport Therapeutics, Inc. | -99.28% |
| ANI Pharmaceuticals, Inc. | 11.55% |
| Corcept Therapeutics, Inc. | -18.92% |
| Assertio Holdings, Inc. | -189.8% |
| Veru, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -567.3% |
| Return on Assets | -52.54% |
| Return on Invested Capital | -144.2% |
| Gross Profit Margin (Quarterly) | 90.92% |
| Operating Margin (Quarterly) | -27.05% |
| Return on Net Operating Assets | -96.66% |